Table 2 Risk of dyslipidemia across tertiles of α-carotene consumption in participants of Tehran Lipid and Glucose Study.
α-carotene consumption (mcg/day) | T 1 | T 2 | T 3 | P for trend |
|---|---|---|---|---|
High-TG | ||||
Range of α-carotene consumption (mcg/d) | ≤ 450.1 | 450.2-920.3 | ≥ 920.4 | |
Participants/ cases (n/n) | 427/171 | 414/155 | 438/169 | |
Crude | 1.00 | 0.93 (0.74–1.16) | 0.93 (0.75–1.15) | 0.577 |
Model 1 | 1.00 | 0.91 (0.72–1.13) | 0.91 (0.73–1.13) | 0.476 |
Model 2 | 1.00 | 0.91 (0.72–1.14) | 0.92 (0.73–1.17) | 0.600 |
High-LDL | ||||
Range of α-carotene consumption (mcg/d) | ≤ 443.9 | 444.0-877.2 | ≥ 877.3 | |
Participants/ cases (n/n) | 451/169 | 447/175 | 428/156 | |
Crude | 1.00 | 1.07 (0.86–1.33) | 0.96 (0.76–1.20) | 0.563 |
Model 1 | 1.00 | 1.02 (0.82–1.27) | 0.87 (0.69–1.09) | 0.172 |
Model 2 | 1.00 | 1.07 (0.85–1.33) | 0.97 (0.76–1.25) | 0.700 |
High-total cholesterol | ||||
Range of α-carotene consumption (mcg/d) | ≤ 436.9 | 437.0-875.8 | ≥ 875.9 | |
Participants/ cases (n/n) | 455/206 | 430/189 | 426/195 | |
Crude | 1.00 | 0.90 (0.73–1.11) | 0.97 (0.79–1.19) | 0.952 |
Model 1 | 1.00 | 0.87 (0.71–1.07) | 0.87 (0.71–1.07) | 0.293 |
Model 2 | 1.00 | 0.91 (0.73–1.12) | 0.97 (0.77–1.21) | 0.934 |
Low-HDL | ||||
Range of α-carotene consumption (mcg/d) | ≤ 437.2 | 437.3-886.2 | ≥ 886.3 | |
Participants/ cases (n/n) | 246/86 | 238/89 | 227/79 | |
Crude | 1.00 | 1.05 (0.77–1.43) | 0.98 (0.71–1.34) | 0.827 |
Model 1 | 1.00 | 1.06 (0.78–1.45) | 0.90 (0.66–1.25) | 0.468 |
Model 2 | 1.00 | 1.01 (0.74–1.40) | 0.83 (0.59–1.17) | 0.234 |
